Skip to main content
Infectious diseases

Research and statistics

Skip to results
374 results that are All research and statistics, sorted by Updated (newest)
  • Graphs showing cumulative strain characterisation data for enterovirus.

  • Reports presenting annual epidemiological data for HIV in Yorkshire and Humber.

  • Latest hepatitis D virus (HDV) reports and supporting documents, for England and the UK.

  • Qualitative assessment of the risk of avian influenza A(H5N1) infections in non-avian UK species present to the UK public.

  • Listeriosis usually presents as self-limiting gastroenteritis but invasive listeriosis is a concern for high risk groups such as the elderly and pregnant women.

  • Notifications of scarlet fever disease in England and data from invasive Group A streptococci (iGAS) surveillance.

  • Epidemiological data for typhoid and paratyphoid (enteric fever).

  • Notifications, deaths and laboratory isolates data for England and Wales.

  • Laboratory-confirmed cases of invasive meningococcal disease reported to the enhanced meningococcal surveillance programme in England.

  • Annual data on reported cases of diphtheria in England, with epidemiological commentary.

  • Technical reports related to the investigation of acute hepatitis cases of unknown aetiology that occurred in children in England in 2022.

  • Update to end of December 2022 on enhanced surveillance of potentially iatrogenic CJD exposures -- occasional reports related to human prion disease surveys.

  • Weekly statistics taken from the NHS COVID-19 app. This data is no longer being updated.

  • Laboratory-confirmed cases of hepatitis A.

  • Monthly report presenting the latest data on COVID-19 mortality in England in people with laboratory-confirmed SARS-CoV-2.

  • The use of testing within the National Testing Programme (NTP) and answers to questions asked by the media and the public.

  • Qualitative assessment of the risk that tick-borne encephalitis (TBE) virus presents to the UK human population.

  • A report on using neutralising monoclonal antibodies (nMABs) in a prophylaxis setting for patients with highest-risk of hospitalisation or death from COVID-19.

  • An expert panel statement, informed by evidence and expertise, on the role of face coverings in mitigating COVID-19 transmission.

  • This report describes the extent of infections and injecting-related harms among people who inject drugs (PWID) in the United Kingdom.